Showing results (471-480 of 895) with videos related to
Sort By:
Pageof 90
Journal of the American College of Cardiology|August 20, 2016
Assessing the Impact of Medication Adherence on Long-Term Cardiovascular OutcomesSameer Bansilal, Jose Maria Castellano, Ester Garrido, et al.JAMA Cardiology|May 18, 2022
Rare and Common Genetic Variation Underlying the Risk of Hypertrophic Cardiomyopathy in a National BiobankKiran J Biddinger, Sean J Jurgens, Dimitri Maamari, et al.Journal of Cardiovascular Electrophysiology|April 15, 2005
The clinical implications of cumulative right ventricular pacing in the multicenter automatic defibrillator trial IIJonathan S Steinberg, Avi Fischer, Paul Wang, et al.Vascular Medicine (London, England)|September 14, 2013
Warfarin pharmacogenetics: a controlled dose-response study in healthy subjectsDaniella L Kadian-Dodov, Sarina A van der Zee, Stuart A Scott, et al.American Heart Journal|December 17, 2011
Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring StudyMichiel Rienstra, Jenny X Sun, Steven A Lubitz, et al.Journal of Human Genetics|April 18, 2023
Common and rare variants associated with cardiometabolic traits across 98,622 whole-genome sequences in the All of Us research programXin Wang, Justine Ryu, Jihoon Kim, et al.Circulation|March 2, 2022
Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: VITAL-AF Randomized Controlled TrialSteven A Lubitz, Steven J Atlas, Jeffrey M Ashburner, et al.Cardiovascular Digital Health Journal|April 27, 2023
Artificial intelligence-enabled classification of hypertrophic heart diseases using electrocardiogramsJulian S Haimovich, Nate Diamant, Shaan Khurshid, et al.American Heart Journal|July 22, 2019
Design and rationale of a pragmatic trial integrating routine screening for atrial fibrillation at primary care visits: The VITAL-AF trialJeffrey M Ashburner, Steven J Atlas, David D McManus, et al.European Heart Journal. Quality of Care & Clinical Outcomes|August 30, 2021
Types of myocardial injury and mid-term outcomes in patients with COVID-19Annapoorna Kini, Davide Cao, Matteo Nardin, et al.Pageof 90